Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» AstraZeneca CEO: M&A 'often disruptive;' company posts higher revenues, but declining profits
AstraZeneca CEO: M&A 'often disruptive;' company posts higher revenues, but declining profits
AstraZeneca CEO: M&A 'often disruptive;' company posts higher revenues, but declining profits
Submitted by
admin
on April 24, 2014 - 7:19am
Source:
CNBC
News Tags:
Pharma CEOs
Pfizer
Pascal Soriot
M&A
earnings
AstraZeneca
Headline:
AstraZeneca CEO: M&A 'often disruptive;' company posts higher revenues, but declining profits
Do Not Allow Advertisers to Use My Personal information
